Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

The etiological effect of a new low-frequency ESR1 variant on Mild Cognitive Impairment and Alzheimer's Disease: a population-based study.

Li X, Zhu X, Zhang W, Yang F, Hui J, Tan J, Xie H, Peng D, Ma L, Cui L, Zhang S, Lv Z, Sun L, Yuan H, Zhou Q, Wang L, Qi S, Wang Z, Hu C, Yang Z.

Aging (Albany NY). 2018 Sep 16;10(9):2316-2337. doi: 10.18632/aging.101548.

2.

Chronic Amyloid β Oligomer Infusion Evokes Sustained Inflammation and Microglial Changes in the Rat Hippocampus via NLRP3.

Fekete C, Vastagh C, Dénes Á, Hrabovszky E, Nyiri G, Kalló I, Liposits Z, Sárvári M.

Neuroscience. 2018 Mar 6. pii: S0306-4522(18)30171-4. doi: 10.1016/j.neuroscience.2018.02.046. [Epub ahead of print]

PMID:
29522854
3.

BARHL1 Is Downregulated in Alzheimer's Disease and May Regulate Cognitive Functions through ESR1 and Multiple Pathways.

Barh D, García-Solano ME, Tiwari S, Bhattacharya A, Jain N, Torres-Moreno D, Ferri B, Silva A, Azevedo V, Ghosh P, Blum K, Conesa-Zamora P, Perry G.

Genes (Basel). 2017 Sep 28;8(10). pii: E245. doi: 10.3390/genes8100245.

4.

Genetic Polymorphisms in Estrogen Metabolic Pathway Associated with Risks of Alzheimer's Disease: Evidence from a Southern Chinese Population.

Chen LH, Fan YH, Kao PY, Ho DT, Ha JC, Chu LW, Song YQ.

J Am Geriatr Soc. 2017 Feb;65(2):332-339. doi: 10.1111/jgs.14537. Epub 2017 Jan 19.

PMID:
28102888
5.

Estrogen receptor beta polymorphisms and cognitive performance in women: associations and modifications by genetic and environmental influences.

Fehsel K, Schikowski T, Jänner M, Hüls A, Voussoughi M, Schulte T, Vierkötter A, Teichert T, Herder C, Sugiri D, Krämer U, Luckhaus C.

J Neural Transm (Vienna). 2016 Dec;123(12):1369-1379. Epub 2016 Sep 14.

PMID:
27629499
6.

Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease.

Landel V, Millet P, Baranger K, Loriod B, Féron F.

Mol Neurodegener. 2016 Mar 1;11:22. doi: 10.1186/s13024-016-0087-2.

7.

Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.

Rezazadeh M, Khorrami A, Yeghaneh T, Talebi M, Kiani SJ, Heshmati Y, Gharesouran J.

Neuromolecular Med. 2016 Mar;18(1):37-49. doi: 10.1007/s12017-015-8376-4. Epub 2015 Nov 9.

PMID:
26553058
8.

Influence of family history of dementia in the development and progression of late-onset Alzheimer's disease.

Scarabino D, Gambina G, Broggio E, Pelliccia F, Corbo RM.

Am J Med Genet B Neuropsychiatr Genet. 2016 Mar;171B(2):250-6. doi: 10.1002/ajmg.b.32399. Epub 2015 Nov 4.

PMID:
26531229
9.

Estrogen receptor 1 PvuII and XbaI polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis.

Lee YH, Song GG.

Genet Mol Res. 2015 Aug 10;14(3):9361-9. doi: 10.4238/2015.August.10.17.

10.

Effects of genetic variation on the dynamics of neurodegeneration in Alzheimer's disease.

Printy BP, Verma N, Cowperthwaite MC, Markey MK; Alzheimer's Disease Neuroimaging Initiative.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:2464-7. doi: 10.1109/EMBC.2014.6944121.

PMID:
25570489
11.

Estrogen receptor α gene polymorphisms and risk of Alzheimer's disease: evidence from a meta-analysis.

Cheng D, Liang B, Hao Y, Zhou W.

Clin Interv Aging. 2014 Jun 30;9:1031-8. doi: 10.2147/CIA.S65921. eCollection 2014.

12.

Meta-analysis of PvuII, XbaI variants in ESR1 gene and the risk of Alzheimer's disease: the regional European difference.

Wang T.

Neurosci Lett. 2014 Jun 27;574:41-6. doi: 10.1016/j.neulet.2014.05.017. Epub 2014 May 22.

PMID:
24857745
13.

Estrogen receptor α variants affect age at onset of Alzheimer's disease in a multiethnic female cohort.

Janicki SC, Park N, Cheng R, Clark LN, Lee JH, Schupf N.

Dement Geriatr Cogn Disord. 2014;38(3-4):200-13. doi: 10.1159/000355559. Epub 2014 Apr 8.

14.

Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease.

Scacchi R, Gambina G, Broggio E, Corbo RM.

Int J Geriatr Psychiatry. 2014 Jun;29(6):610-5. doi: 10.1002/gps.4043. Epub 2013 Oct 22.

PMID:
24150894
15.

Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE {varepsilon}4 carriers: a case-control study.

Fernández-Martínez M, Elcoroaristizabal Martín X, Blanco Martín E, Galdos Alcelay L, Ugarriza Serrano I, Gómez Busto F, Alvarez-Álvarez M, Molano Salazar A, Bereincua Gandarias R, Inglés Borda S, Uterga Valiente JM, Indakoetxea Juanbeltz B, Gómez Beldarraín MÁ, Moraza López J, Barandiarán Amillano M, M de Pancorbo M.

BMJ Open. 2013 Sep 18;3(9):e003200. doi: 10.1136/bmjopen-2013-003200.

16.

Estrogen: a master regulator of bioenergetic systems in the brain and body.

Rettberg JR, Yao J, Brinton RD.

Front Neuroendocrinol. 2014 Jan;35(1):8-30. doi: 10.1016/j.yfrne.2013.08.001. Epub 2013 Aug 29. Review.

17.

Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.

Ma SL, Tang NL, Leung GT, Fung AW, Lam LC.

Am J Geriatr Psychiatry. 2014 May;22(5):489-98. doi: 10.1016/j.jagp.2012.08.006. Epub 2013 Jan 11.

PMID:
23567436
18.

Estrogen receptor polymorphisms and incident dementia: the prospective 3C study.

Ryan J, Carrière I, Carcaillon L, Dartigues JF, Auriacombe S, Rouaud O, Berr C, Ritchie K, Scarabin PY, Ancelin ML.

Alzheimers Dement. 2014 Jan;10(1):27-35. doi: 10.1016/j.jalz.2012.12.008. Epub 2013 Mar 13.

19.

Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.

Elcoroaristizabal Martín X, Fernández Martínez M, Galdos Alcelay L, Molano Salazar A, Bereincua Gandarias R, Inglés Borda S, Gómez Busto F, Uterga Valiente JM, Indakoetxea Juanbeltz B, Gómez Beldarraín MA, de Pancorbo MM.

Dement Geriatr Cogn Disord. 2011;32(5):332-41. doi: 10.1159/000335541. Epub 2012 Feb 3.

PMID:
22311091
20.

Study of estrogen receptor-α and receptor-β gene polymorphisms on Alzheimer's disease.

Goumidi L, Dahlman-Wright K, Tapia-Paez I, Matsson H, Pasquier F, Amouyel P, Kere J, Lambert JC, Meirhaeghe A.

J Alzheimers Dis. 2011;26(3):431-9. doi: 10.3233/JAD-2011-110362.

PMID:
21673408

Supplemental Content

Loading ...
Support Center